Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Intensification in Infant ALL: A Children's Oncology Group Study
NCT00002756Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Jun 1996
- Primary completion
- Sep 2007
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
Phase 2, open-label, single-arm trial of methotrexate, cyclophosphamide and etoposide in acute lymphoblastic leukemia (ALL), sponsored by Children's Oncology Group. Primary endpoints: Feasibility of intensification, Event-free survival and 1 more. Started Jun 1996; status: completed.
02
Drugs
methotrexatecyclophosphamideetoposide
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00002756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002756.